PNC Managed Account Solutions’s Novartis NVS Stock Holding History

PNC Managed Account Solutions’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$366K	Buy	+4,010	New	+$357K	0.07%	151

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PNC Managed Account Solutions's NVS Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Novartis (NVS) in Q2 2021: 4,010 shares worth $366K. The stake represents 0.07% of the portfolio and ranks #151 among its holdings.

1,119 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

PNC Managed Account Solutions held 4,010 shares of Novartis worth $366K as of Q2 2021.
Novartis was a new PNC Managed Account Solutions position in Q2 2021.
Novartis made up 0.07% of PNC Managed Account Solutions's portfolio in Q2 2021, its #151 holding.
1,119 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.